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Introduction
Despite the wide use of vitamin and mineral supple-
ments in different populations, the effects of such a
practice on health have not been well defined [20].
Several studies [16, 17, 19] reported that supplement
usage is beneficial for primary and secondary pre-
vention of some diseases and improves quality of life.
Holmquist et al. [17] study indicated that using of low
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j Abstract Background It is
hypothesis that in relatively
healthy older people supplement
usage can be consider as healthy
life style habit and as such can
positively influence longevity. Aim
of the study To determine
whether supplement use was
associated with all-cause mortality
in the participants of the SENECA
study. Methods Baseline mea-
surements were carried out in
1988/1989 among 75 to 80-year-
old people living in 15 European
small towns. All-cause mortality
was followed up to April 30, 1999.
Data from 920 men and 980
women who were ischemic heart
diseases-, stroke- and cancer-free
at baseline were included. The
multivariate adjusted (for sex, age,
years of education, physical activ-
ity, BMI, chronic diseases, Medi-
terranean Diet Score, alcohol use
and the place of living) hazard
ratio (HRs) and 95% confidence
intervals (CIs) of mortality by use
of any type of nutrient supplement
and by particular nutrient supple-
ment use were estimated by Cox
proportional hazards regression
models. Results At baseline, 13%
of participants used nutritional
supplements, 19% of subjects were
smokers. During 10 years of fol-
low-up 445 men and 252 women
died. Among non-smokers no
significant associations between
total supplement use and particu-
lar nutrient supplement use were
observed. Among smokers use
of any type of supplements
(Multivariate HR: 1.52; 95%CI:
1.02–2.28), use of vitamin B1
(Multivariate HR: 1.57; 95%CI:
1.00–2.48) and vitamin B2 supple-
ments (Multivariate HR: 1.60;
95%CI: 1.00–2.56) were associated
with a significantly higher risk of
all-cause mortality. The similar
tendencies were observed among
vitamin B6 and vitamin C supple-
ment users who were smokers.
Conclusions Among smokers,
participants of the SENECA study,
supplement use increased all-
cause mortality risk.
j Key words elderly –
Europe – supplement use –
mortality – smoking
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doses of multivitamin supplements was relevant to
lowering risk of myocardial infraction. Jacobs et al.
[18, 19] observed significant decreased the risk of
stomach cancer mortality among vitamin C users and
colon cancer mortality among multivitamin supple-
ments users. In contrast other studies [15, 18, 20, 28,
34 and 41] have failed to demonstrate the positive
effect of supplementation in preventing age-related
diseases.
The baseline round of the Survey in Europe on
Nutrition and the Elderly, a Concerted Action (SEN-
ECA) revealed, on the basis of the blood analyses, a
significant prevalence of deficiency for several nutri-
ents including vitamin B6 (up to 50% of subjects),
vitamin B12 (2–10%) and vitamin E (1–21%) among
older people from small European towns [13]. To
counteract low nutritional status only 13% of
respondents reported having taken nutritional sup-
plements [1]. The aim of this paper was to determine
whether the use of supplements was associated with
health benefits, measured as lowering all-causes
mortality in the participants of SENECA study.
Subjects and methods
j Study population
Data presented in this paper were collected at baseline
(1988/1989) and final (1999) round of the SENECA
survey. The population under study consisted of
randomly selected, born between 1913 and 1918,
habitants of 15 small towns in 11 European countries:
Hamme (B), Roskilde (DK), Haguenau and Romans
(F), Anogia and Archanes (GR), Monor (H), Padua,
Fara Sabina, Magliano Sabina and Poggio Mirteto (I),
Culemborg (NL), Vila Franca de Xira (P), Betanzos
(E), Yverdon-les-Bains, Burgdorf and Bellinzona
(CH), Marki (PL) [11].
In view of a poor prognosis and the high risk of
death, subjects who suffered from ischemic heart
diseases (376 subjects), stroke (63 subjects) and
malignancy (46 subjects) were excluded. Finally, the
analyses included 920 men and 980 women.
j Data collection
Data were collected by interview at the participants’
homes according to a standardised protocol [10].
Information about use of pharmaceutical prepara-
tions containing vitamins or/and minerals was col-
lected with the question: ‘‘Do you use medicines,
vitamins/minerals (tablets or injections) or tonics? If
yes, please show them.’’ Participants were also asked
about daily doses. Having data on the composition of
supplements available for subjects the intake of 9
vitamins, calcium and iron were calculated on the
local level.
Modified dietary history method was used to col-
lect information about food consumption during the
month before the interview. This method was vali-
dated against a 3-day weight record method in a
subsample of 82 elderly subjects from 11 participating
centres. Pearson’s correlation coefficient for nutrient
intake varied from 0.18 (vitamin A) to 0.79 (water)
with a median coefficient of 0.58 [29]. The quality of
diet was assessed by modified Mediterranean Diet
Score (MDS) which comprised: ratio of MUFA to SFA;
intake of: legumes, nuts, and seeds; cereal products
and grains; fruits; vegetables and potatoes; meat and
meat products; dairy products; and fish. The diet
score varied from 0 (low quality diet) to 8 (high
quality diet) [22].
Vorrips questionnaire was used to assess habitual
physical activities of the last year. Items on household
activities were estimated from very active to inactive
(4–5 possible ratings). Sports and other activities were
determined as type of activity; hours per day or week
spend on it, and the period of the year in which the
activity was normally performed. The value of Voo-
rrips Score was calculated on bases on the net ener-
getic cost of particular activities [40].
Non-smoking subjects were defined as never
smoking or non-smoking since more than 15 years
ago at baseline round of the study. Data about mor-
tality were collected up to April 30, 1999.
j Statistical analysis
All statistical analyses were done using the SPSS
software (v.11.0). Because there were statistically sig-
nificant interactions between smoking status of par-
ticipants and use of any type of nutrient supplements
as well as use of particular nutrient supplements, all
the analyses were carried out separately for smokers
and non-smokers.
The unadjusted Kaplan–Meier curves by supple-
ment use and smoking status were fitted, and log-rank
test was used to compare survival distribution
between supplement users and non-users. Cox pro-
portional hazards regression models were used to
estimate the hazard ratios (HRs) and 95% confidence
intervals (CIs) of mortality for users of any type of
nutrient supplements as well as for users of particular
nutrient supplements (vitamin B1, B2, B6, B12, C, A, D,
E, folic acid, calcium and iron, separately) versus non-
users. Multivariate HRs estimates and 95% CIs were
adjusted for sex (men, women), age (continuous
variable), years of education (continuous variable),
physical activity (Voorrips Score: £8 points, >8 points),
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BMI (£25 kg/m2, >25 kg/m2), chronic diseases (yes,
no), modified MDS (£4 points, >4 points), alcohol use
(non-consumption, consumption) and the place of
living (latitude £47North, >47North). The statistical
significance was considered at P < 0.05.
Results
j Characteristics of the cohort
At the beginning of the study the mean age of the
subjects was 73.3 ± 1.8 years (Table 1). During the
baseline study, 11% of men and 15% of women used
supplements, 32% of men and 8% of women were
smokers. Fourteen percent of smoking men and 5% of
women smoked more then 25 cigarettes or other
tobaccos per day, 26% of smoking men and 16% of
women smoked 15–24 cigarettes, 26% men and 35%
of women smoked 5–14 cigarettes and other men and
women smoked £4 cigarettes. A high percentage of
study population suffered from chronic diseases (65%
of men and 76% of women) as well as overweight and
obesity (49 and 17% of men and 39 and 25% of wo-
men, respectively). The diets of approximately 40% of
participants were scored above four points of a
modified MDS.
During 10 years of SENECA study 445 men and
252 women died.
j Intake of vitamins and minerals from supplements
in relation to smoking status
A higher percentage of smoking men and smoking
women used supplements (14.4 and 32.9%, respectively)
in comparison to non-smoking subjects (9.2 and 13.4%,
respectively). Vitamins B1, B2 and B6 and C were used
most often among both, smokers and non-smokers,
while folic acid and calcium supplements were used by a
lower number of subjects (Table 2).
The median intake of vitamins and iron from
supplements was in the range of recommendations for
these nutrients while median doses of supplemental
calcium were very low. A part of non-smokers sub-
jects used large doses of iron, the 90th percentile of
supplemental intake of this nutrient amounted 67 mg/
day, what exceeded the upper intake level (25 g/day)
proposed in Nordic Recommendations [30].
Table 1 Description of the population (baseline study)
Men
(N = 920)
Women
(N = 980)
Age (years) means ± SD 73.3 ± 1.8 73.2 ± 1.9
Education (years) means ± SD 8.6 ± 4.1 7.5 ± 3.6
Self-perceived health (%)
Very poor and poor 6.7 10.8
Fair 24.7 31.5
Good and very good 68.3 56.7
Chronic disease (%) 64.5 76.3
Mediterranean diet score, modified (%)
£4 points 60.8 59.9
>4 points 39.2 40.1
Smoking (%) 32.0 7.5
Alcohol use (%) 79.6 49.3
Supplement use (%) 10.9 14.8
Voorrips score (points) means ± SD 18.5 ± 13.4 11.8 ± 9.5
Body mass index (kg/m2) means ± SD 26.6 ± 3.8 27.0 ± 4.7
<20 (%) 3.2 5.4
20–25 (%) 30.5 30.0
25–30 (%) 48.9 39.4
>30 (%) 17.4 25.2
Albumin (g/l) means ± SD 41.9 ± 3.2 41.6 ± 3.0
Table 2 Intake of vitamins and minerals from supplements in relation to smoking status
Nutrient in supplements Supplement users
Non-smoking (N = 176) Smoking (N = 66)
%N Percentiles %N Percentiles
10 50 90 10 50 90
Vitamin B1 (mg/d)
a 57 1.2 2.0 63 71 1.0 2.0 20
Vitamin B2 (mg/d)
a 56 1.5 2.0 26 67 1.0 2.0 8
Vitamin B6 (mg/d)
a 60 0.8 2.0 36 69 0.5 2.0 10
Folic acid (lg/d)a 29 100 100 400 36 50 100 200
Vitamin B12 (lg/d)
a 38 1.7 3.0 249 61 1.0 3.0 600
Vitamin C (mg/d)a 51 16 60 209 68 20 60 200
Vitamin A (lg/d)a 44 200 1,200 3,000 59 300 1,000 4,000
Vitamin D (lg/d)a 43 5 10 26 64 8 10 355
Vitamin E (mg/d)a 44 3 10 103 58 1 10 71
Calcium (mg/d) 35 3 162 1,000 23 5 97 700
Iron (mg/d)a 33 4 16 67 53 2.3 18 22
aSignificant difference in prevalence of supplementation practice between non-smokers and smokers
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j Supplement use and mortality
Among non-smokers unadjusted hazard ratio was a
statistically significantly lower (28%) among supple-
ment users than among non-users (Figure 1). The
similar tendencies were observed among users of
vitamins B1, B2 and B6 and calcium. In contrast,
among smokers there were tendencies towards an
increase in mortality among users of any type of
supplements (37%) as well as among vitamin B1, B2,
B6 and vitamin C supplement users (43–47%) versus
non-users.
After multivariate adjustments (Table 3), among
non-smokers none of the differences in all-cause
mortality related to total or particular nutrients sup-
plement use were statistically significant. Whereas
among smokers the multivariate-adjusted hazard ra-
tio for subjects who used any type of nutrient sup-
plements compare to those who did not use them was
significantly higher (52%, P = 0.04), for vitamin B1
and B2 supplements users HRs were also higher (57
and 60%, respectively, P = 0.05). The similar ten-
dencies were observed among smokers—vitamin B6
and vitamin C supplement users.
Discussion
Our study shows that supplement use is associated
with mortality differently in smoking and non-
smoking elderly and provide no evidence of a bene-
ficial effect of supplement use on the risk of mortality
during 10 years follow-up among SENECA’s popula-
tion. Slight adverse effects were found in smoking
subjects. In smoking subjects the supplement use (any
type or vitamin B1, and B2) was associated with slight
adverse effects.
Some meta-analysis of randomized controlled tri-
als also showed no evidence of a protective effect of
supplement use on mortality or morbidity [3, 5, 6, 8,
9]. No evidences of a protective effect were found in
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Fig. 1 The unadjusted Kaplan–Meier
survival curves for subjects from SENECA’s
baseline study by supplement use and
smoking status
Table 3 Hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause
mortality in SENECA-population by supplement use and smoking status
unadjusted and adjusted for possible confounders
Users of nutrient
supplements
Non-smoking
(N = 1,527)
Smoking
(N = 365)
HR 95% CI HR 95% CI
Unadjusted
Totala 0.72 0.53–0.97 1.37 0.97–1.94
Vitamin B1 0.74 0.50–1.09 1.45 0.98–2.13
Vitamin B2 0.74 0.45–1.02 1.44 0.96–2.15
Vitamin B6 0.67 0.45–1.00 1.43 0.96–2.12
Folic acid 0.73 0.42–1.26 1.14 0.66–1.97
Vitamin B12 0.97 0.62–1.49 1.25 0.82–1.92
Vitamin C 0.76 0.51–1.15 1.47 0.99–2.18
Vitamin A 0.75 0.48–1.16 1.21 0.78–1.87
Vitamin D 0.83 0.54–1.28 1.17 0.76–1.80
Vitamin E 0.86 0.56–1.30 1.13 0.72–1.78
Calcium 0.62 0.37–1.06 0.85 0.40–1.80
Iron 0.68 0.40–1.15 1.27 0.81–2.00
Adjustedb
Totala 0.80 0.57–1.11 1.52 1.02–2.28
Vitamin B1 0.80 0.52–1.23 1.57 1.00–2.48
Vitamin B2 0.71 0.45–1.11 1.60 1.00–2.56
Vitamin B6 0.71 0.46–1.09 1.52 0.96–2.42
Folic acid 0.77 0.42–1.42 1.19 0.64–2.20
Vitamin B12 1.12 0.70–1.79 1.22 0.74–2.00
Vitamin C 0.71 0.45–1.13 1.55 0.97–2.46
Vitamin A 0.82 0.50–1.34 1.22 0.73–2.03
Vitamin D 0.91 0.57–1.46 1.27 0.77–2.11
Vitamin E 0.97 0.62–1.51 1.31 0.78–2.21
Calcium 0.72 0.41–1.26 0.81 0.33–2.00
Iron 0.85 0.49–1.49 1.34 0.79–2.27
aUsers of any type of nutrient supplements
bAdjusted for sex, age, education, physical activity, body mass index, chronic
diseases, Mediterranean Diet Score, alcohol use, latitude
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the case of antioxidant or B-group vitamin supple-
ments on the progression of atherosclerosis [6] and
antioxidant supplements on gastrointestinal cancer
[5], of vitamin C and vitamin E supplements use on
various type of cancer [9], as well as usage of vitamin
A, C, E and folate supplements on prevention of lung
cancer [8]. Moreover, Bjelakovic et al. [4] who ana-
lyzed 68 randomized trials with 232,606 participants
showed that treatment with antioxidant vitamins may
increase all-cause mortality.
However, observational and experimental studies
reported also inverse association between supplement
use and mortality. Slightly decreased risk of colon
cancer mortality among multivitamin users was
observed with stronger association among moderate
to heavy alcohol users. At least 15 years of follow-up
was required to see the benefit of supplement use
[19]. Low doses of multivitamin supplements were
associated with substantially lower risk of nonfatal
myocardial infarction in Stockholm Heart Epidemi-
ology Program [17]. The results of SU.VI.MAX study
indicated that nutritional doses of a combination of
vitamin C, vitamin E, beta-carotene, selenium and
zinc might have a protective effect on mortality
in apparently healthy men in the age of 45–60 years
[16].
Similarly as in our study, the adverse effect of
supplement use on survival among smokers was
reported by others [24, 32, 38, 41]. The b-Carotene
and Retinol Efficacy Trial (CARET) was stopped
21 months earlier than planned because after 4 years
the relative risks of death from any cause, from lung
cancer and from cardiovascular diseases were higher
among subjects who received combination of b-car-
otene and vitamin A than among the placebo group
[32].
Watkins et al. [41] showed that the mortality from
all cancers was significantly higher among smoking
men who used multivitamins alone (HR: 1.13, 95%CI:
1.05–1.23) or in combination with vitamin A, C or E
(HR: 1.16, 95%CI: 1.06–1.23); whereas among subjects
who had never or had formerly smoked and used
supplements hazard ratios were significantly lower,
i.e. 0.86 (95%CI: 0.74–0.99) and 0.90 (95%CI: 0.82–
0.98), respectively.
Moreover, among the participants of the Finnish
ATBC Cancer Prevention Study a-tocopherol supple-
mentation increased the risk for adenomas (HR: 1.66,
95%CI: 1.19–2.32), whereas b-carotene supplementa-
tion had no effect on the risk (HR: 0.98, 95%CI: 0.71–
1.35) [25].
The mechanisms of the adverse effect of supple-
mental vitamins are still not fully explained. Probably,
they could be related to pro-oxidative role of anti-
oxidants when their doses are too high or as the
results of interactions with components of cigarette
smoke. In our study the median intake of supple-
mental nutrients did not exceed significantly the
recommended dietary intake among smokers, but the
90th percentile of intake exceeded three to ten times
the RDA’s for vitamin B1, B2, and C. High dose of
those supplements probably had an adverse effect on
health of participants who were smokers.
In humans different cellular markers of DNA
damage were used to assess the pro-oxidative effects
of vitamin C supplements in smokers. Welch et al.
[42] observed a significant increase of 7-hydroxy-8-
oxo-2¢-deoxyguanosine concentrations after b-caro-
tene supplementation in smokers, whereas in non-
smokers the concentration of this marker decreased.
Rehman et al. [36], who examined the effects of iron
(14 mg/day) and vitamin C (either 60 or 260 mg/day)
supplementation found that in subjects with higher
initial level of plasma vitamin C total oxidative DNA
damage in white blood cells significantly increased
after supplementation. Whereas, in low plasma
ascorbate subjects the supplementation was benefi-
cial.
In clinical trial among smokers who regularly
received 500 mg/day vitamin C a significant increase
of plasma TBARS was shown, what indicated the
increase of oxidative lipid damage [31].
In contrast, others studies were failed in founding
the significant changes in DNA damage or LDL-lipid
peroxidation after supplementation with vitamin C [2,
27], vitamin E [37], b-carotene [12, 35, 39] and vita-
min combinations [33]. Moreover, also protective
effect of supplement use on DNA damage was
observed [7, 14, 23, 26].
Moreover, contrary to expectations high supple-
mental folate levels and folate intervention, after
microscopic neoplastic foci are established in the
colorectal mucosa, promote rather than suppress
colorectal carcinogenesis. The results of animal
studies suggest that folate possesses the dual modu-
lators effect on carcinogenesis depending on the
timing and dose of folate intervention. Folate defi-
ciency has an inhibitory effect whereas folate sup-
plementation has a promoting effect on progression
of established neoplasms [21].
No data on the effect of B-group vitamins supple-
mentation on mortality among smokers was found in
the literature.
Data on vitamin/mineral supplement use presented
in this paper were collected among free-living elderly,
aged at the beginning of the study 70–75 years. At
that time the prevalence of supplement use was rather
small, i.e. 13%. Even the subjects were asked about
current supplement use many of them were long-term
users. Of the 1,043 participants who were reinter-
viewed in 1993 12% reported using supplements
at baseline and after 5 years, 69% of participants
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reported not using supplements at either time.
A potential limitation of this study was the change in
classification of 19% of the respondents after 5 years
from the beginning of the study, i.e. 5% gave up this
practice and 14% became supplement users. Our
reference group therefore included some participants
who become users after 5 years of observation. An-
other limitation was related to a statistical significant
interaction between supplements use and smoking
status of the participants. Dividing subjects into
smokers and non-smokers groups made the sub-
groups small in number of cases and decreased the
power of analysis.
In summary, supplementation practice had no
beneficial effect on mortality among 70 to 75-year-old
European participants of SENECA population. Our
results indicated that some supplements should be
used with special cautiously, and further studies are
necessary, which also would allow for explanation of
the mechanisms of harmful effects of supplements
among smoking subjects.
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